BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29886537)

  • 1. Analysis of Covalent Modifications of Amyloidogenic Proteins Using Two-Dimensional Electrophoresis: Prion Protein and Its Sialylation.
    Katorcha E; Baskakov IV
    Methods Mol Biol; 2018; 1779():241-255. PubMed ID: 29886537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation Controls Prion Fate
    Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
    J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-conversion sialylation of prions in lymphoid tissues.
    Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sialylation of N-linked glycans in prion pathogenesis.
    Makarava N; Baskakov IV
    Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
    Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
    Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.
    Katorcha E; Srivastava S; Klimova N; Baskakov IV
    J Biol Chem; 2016 Aug; 291(33):17009-19. PubMed ID: 27317661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in ST6GAL1, one of the two α2,6-sialyltransferases, has only a minor effect on the pathogenesis of prion disease.
    Makarava N; Katorcha E; Chang JC; Lau JTY; Baskakov IV
    Front Mol Biosci; 2022; 9():1058602. PubMed ID: 36452458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
    Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
    Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparagine-linked glycosylation of the scrapie and cellular prion proteins.
    Haraguchi T; Fisher S; Olofsson S; Endo T; Groth D; Tarentino A; Borchelt DR; Teplow D; Hood L; Burlingame A
    Arch Biochem Biophys; 1989 Oct; 274(1):1-13. PubMed ID: 2505674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modifications define course of prion strain adaptation and disease phenotype.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    J Clin Invest; 2020 Aug; 130(8):4382-4395. PubMed ID: 32484800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sialylation in prion disease pathogenesis and prion structure.
    Baskakov IV
    Prog Mol Biol Transl Sci; 2020; 175():31-52. PubMed ID: 32958238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein functions and dysfunction in prion diseases.
    Sakudo A; Ikuta K
    Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.